From these findings, the following hypothesis has been generated: stimulating the GLP-1 receptor with respective agonists has a potential to cause pancreatitis, perhaps chronic pancreatitis, and in the long term, potentially even pancreatic cancer (35)
Samec, M., Liskova, A., Koklesova, L., Samuel, S
Rebalancing the Gut: Glucagon-Like Peptide-1 Agonists as a Strategy for Obesity and Metabolic Health
Injecting on the same day each week helps maintain stable levels and makes it easier to track your protocol
Patients are encouraged to speak with their GP or a specialist weight management service to explore currently available, approved treatment options
This article shares all the details on GLP-1 transdermal patches, their ingredients, who they can help, whether they really help you lose weight, and the future of transdermal drug delivery systems for weight loss